AZD5004 / AstraZeneca, Eccogene  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5004 / AstraZeneca
NCT05654831: FTIH of ECC5004 in Healthy and Diabetic Participants

Recruiting
1
64
US
Placebo, ECC5004
Eccogene
Type 2 Diabetes Mellitus
10/23
10/23
NCT06268145: ECC5004 RBA FE Study in Healthy Participants

Recruiting
1
14
US
ECC5004
Eccogene
Type 2 Diabetes Mellitus
03/24
03/24
NCT06293742: ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

Recruiting
1
64
US
ECC5004, Midazolam, Rosuvastatin, Digoxin, Atorvastatin
Eccogene
Type 2 Diabetes Mellitus
04/24
04/24

Download Options